Asthama Spacers Market to Expand with Growing Prevalence of Respiratory Diseases
The key market players are considering implementing eco-friendly initiatives. Technology and development have helped the market to expand as it is fulfilling the requirements of customers worldwide.
Let’s get to the basics first – So What is Asthma?
Asthma is a chronic disease that affects both adult and children. Owing to the tightness and inflammation of the muscles around the passage of the lungs, the air passage in the lungs become constricted which further leads to asthma. Some of the symptoms which are associated with asthma are cough, chest tightness, shortness of breath, and wheezing. An asthma spacer is a tube-shaped which holds chamber. By the help of asthma spacer medication is given straight to the lungs. The asthma spacer is tremendously useful when using a puffer, which is also known as a metered-dose inhaler (MDI). Basically, spacers have a one- way valve which allows the addict to inhale the drug while exhaling and inhaling in a normal manner, which can also be known as valve holding chambers (VHC).
What are the Types of Asthma?
Bronchial asthma is a very common type of asthma. It affects a major organ bronchi (main air passages) in the lungs. Other types of asthma include nocturnal asthma, onset asthma, childhood asthma, adult-onset asthma, allergic asthma, etc.
How is the Increasing prevalence of respiratory diseases driving the market?
Increasing demand of asthma spacer is because of the increasing incidences of respiratory diseases, which can be accounted as a major driving factor for the growth of global asthma spacer market. Various factors such as urbanization, exposure to tobacco smoke and viral respiratory infections, allergic conditions including eczema and rhinitis (hay fever), are linked to an increased risk of developing asthma, which is driving the growth of the market. The global asthma spacer market was valued USD 1,367.04 million in 2021 and is projected to exhibit a robust 5.8% CAGR during the forecast period.
Reasons for respiratory diseases:
Due to increasing pollution, respiratory diseases such as asthma are becoming alarmingly prevalent. The World Health Organization anticipates that India has near about 20 million asthma patients. Asthma usually strikes children who are in an age group of 5 to 11.
During respiration, the air that we breathe in goes through the throat, nose, and into the lungs. Wide exposure to various environmental irritants and allergens, including outdoor and indoor air pollution is considered to increase the risk of asthma. For example, in October 2018, according to U.S. Environmental Protection Agency, air pollution can provoke asthma symptoms and can bring on asthma attacks.
Alternative treatments hinder the market:
Alternative treatment for asthma is a major factor which is hampering the global asthma spacer market growth during the projected period. Asthma could be treated with bronchial thermoplasty. It is a proved alternative treatment for asthma. For example, in May 2017, Boston Scientific, a medical device designer, announced positive findings from the Post approbation clinical test valuating Bronchial Thermoplasty (BT) in Severe Patient Asthma (PAS2) study, which included cases treated with the Alair BT System. Therefore, the findings showed that BT reduced complications in adult cases with severe patient asthma.
Major trends in Asthma Spacer:
A new approach is being developed to possess a high impact on the treatment of coronavirus in South Africa. The Red Cross War Memorial Children's Hospital in Cape Town is launching the bottle spacer program to bridge the gap between precious marketable spacers and the demands of low- income communities. Rather of precious dividers, the crew has tested and estimated the efficacity of using plastic bottle spacers. The plastic bottle spacers are effortlessly available and cost effective, due to which the crucial players in the demand have started making innovative products with this approach. This trend will increase growth chances for the asthma spacer demand over the forecasting period.
Stanford's Design and Medical academies have banded to develop a low- cost, extensively distributable result, known as Respira spacers. The flat- pack, foldable paper Respira spacers can be packed in hundreds for lower than the cost of a stamp, due to a cost reduction of over 99. The disposable paper mug is readily available, affordable, and eliminatescross-infection, as it's a single- use device.
Impact of Coronavirus (COVID-19) Pandemic:
The coronavirus (COVID-19) pandemic and lockdown in different countries worldwide has impacted the financial status of businesses in each and every sector. The private healthcare sector is one of the sectors, which is majorly impacted by the COVID-19. The lockdown in different countries has created financial burden on the private healthcare sector. Healthcare providers are facing many challenges with regards to resources, equipment, manpower, consumables, and other resources to ensure safety of patients with various other diseases, and declining outpatients’ visits, among others.
Major Companies operating in the Asthma Spacer market are:
Trudell Medical Internationa (London), Pari Gmbh (Germany), GlaxoSmihKline plc (U.K), Medical Development International (Auatralia), Cipla (Mumbai), Lupin (Mumbai), Clement Clarke (U.K).